COMPANY

VerImmune

Keywords: oncology cancer

Location: Washington, DC · source · Oct 15, 2026

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Undisclosed round · $500K · announced Nov 24, 2025 Company release ↗
Source quote
- Nov 24, 2025 · Company release ↗
  “COLUMBIA, Md., (November 24, 2025) — TEDCO , Maryland’s economic engine for technology companies, announced a recent $500,000 Maryland Equity Investment Fund (MEIF) investment in VerImmune, Inc”
Raise Pre-Series A · $4.5M · announced Sep 23, 2024 Company release ↗
Source quote
- Sep 23, 2024 · Company release ↗
  “-- VerImmune Inc., ("VerImmune"), a venture-backed biotechnology company developing a groundbreaking Virus-inspired Particle (ViP™) platform technology, today announced the successful first closing of $4.5 million in its Pre-Series A financing round”

Raises announced in these releases: $5M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Nov 24, 2025 Raise Private equity round: $500,000 (total, as published), announced Nov 24, 2025. Source: company's own press page. source ↗
Nov 24, 2025 Raise Undisclosed round · $500K source ↗
Apr 30, 2025 Grant Government grant: $470,000 (total, as published), announced Apr 30, 2025. Source: company's own press page. source ↗
Sep 23, 2024 Raise Pre-Series A · $4.5M source ↗

Raised: $500K. Last 2 years.

Nov 24, 2025 Private equity round: $500,000 (total, as published), announced Nov 24, 2025. Source: company's own press page. source ↗
Apr 30, 2025 Government grant: $470,000 (total, as published), announced Apr 30, 2025. Source: company's own press page. source ↗